111 related articles for article (PubMed ID: 10501242)
1. AIDS vaccination studies using feline immunodeficiency virus as a model: immunisation with inactivated whole virus suppresses viraemia levels following intravaginal challenge with infected cells but not following intravenous challenge with cell-free virus.
Matteucci D; Pistello M; Mazzetti P; Giannecchini S; Isola P; Merico A; Zaccaro L; Rizzuti A; Bendinelli M
Vaccine; 1999 Aug; 18(1-2):119-30. PubMed ID: 10501242
[TBL] [Abstract][Full Text] [Related]
2. Prime-boost vaccination using DNA and whole inactivated virus vaccines provides limited protection against virulent feline immunodeficiency virus.
Dunham SP; Bruce J; Klein D; Flynn JN; Golder MC; MacDonald S; Jarrett O; Neil JC
Vaccine; 2006 Nov; 24(49-50):7095-108. PubMed ID: 17049683
[TBL] [Abstract][Full Text] [Related]
3. Efficacy evaluation of prime-boost protocol: canarypoxvirus-based feline immunodeficiency virus (FIV) vaccine and inactivated FIV-infected cell vaccine against heterologous FIV challenge in cats.
Tellier MC; Pu R; Pollock D; Vitsky A; Tartaglia J; Paoletti E; Yamamoto JK
AIDS; 1998 Jan; 12(1):11-8. PubMed ID: 9456250
[TBL] [Abstract][Full Text] [Related]
4. AIDS vaccination studies using an ex vivo feline immunodeficiency virus model: failure to protect and possible enhancement of challenge infection by four cell-based vaccines prepared with autologous lymphoblasts.
Giannecchini S; Isola P; Sichi O; Matteucci D; Pistello M; Zaccaro L; Del Mauro D; Bendinelli M
J Virol; 2002 Jul; 76(14):6882-92. PubMed ID: 12072489
[TBL] [Abstract][Full Text] [Related]
5. Involvement of gag- and env-specific cytotoxic T lymphocytes in protective immunity to feline immunodeficiency virus.
Flynn JN; Beatty JA; Cannon CA; Stephens EB; Hosie MJ; Neil JC; Jarrett O
AIDS Res Hum Retroviruses; 1995 Sep; 11(9):1107-13. PubMed ID: 8554908
[TBL] [Abstract][Full Text] [Related]
6. Experimental vaccine protection against feline immunodeficiency virus.
Yamamoto JK; Okuda T; Ackley CD; Louie H; Pembroke E; Zochlinski H; Munn RJ; Gardner MB
AIDS Res Hum Retroviruses; 1991 Nov; 7(11):911-22. PubMed ID: 1662057
[TBL] [Abstract][Full Text] [Related]
7. Protection against homologous but not heterologous challenge induced by inactivated feline immunodeficiency virus vaccines.
Hosie MJ; Osborne R; Yamamoto JK; Neil JC; Jarrett O
J Virol; 1995 Feb; 69(2):1253-5. PubMed ID: 7815500
[TBL] [Abstract][Full Text] [Related]
8. Vaccination with fixed feline immunodeficiency virus (FIV) infected cells: protection, breakthrough and specificity of response.
Bishop SA; Stokes CR; Gruffydd-Jones TJ; Whiting CV; Humphries JE; Osborne R; Papanastasopoulou M; Harbour DA
Vaccine; 1996 Sep; 14(13):1243-50. PubMed ID: 8961513
[TBL] [Abstract][Full Text] [Related]
9. Suppression of virus burden by immunization with feline immunodeficiency virus Env protein.
Hosie MJ; Dunsford TH; de Ronde A; Willett BJ; Cannon CA; Neil JC; Jarrett O
Vaccine; 1996 Apr; 14(5):405-11. PubMed ID: 8735552
[TBL] [Abstract][Full Text] [Related]
10. Enhancement after feline immunodeficiency virus vaccination.
Hosie MJ; Osborne R; Reid G; Neil JC; Jarrett O
Vet Immunol Immunopathol; 1992 Dec; 35(1-2):191-7. PubMed ID: 1337397
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of feline monocyte-derived dendritic cells loaded with internally inactivated virus as a vaccine against feline immunodeficiency virus.
Freer G; Matteucci D; Mazzetti P; Tarabella F; Catalucci V; Ricci E; Merico A; Bozzacco L; Pistello M; Bendinelli M
Clin Vaccine Immunol; 2008 Mar; 15(3):452-9. PubMed ID: 18216184
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of a feline immunodeficiency virus vaccine.
Huang C; Conlee D; Loop J; Champ D; Gill M; Chu HJ
Anim Health Res Rev; 2004 Dec; 5(2):295-300. PubMed ID: 15984343
[TBL] [Abstract][Full Text] [Related]
13. Mechanism(s) of FIV vaccine protection.
Pu R; Tellier MC; Yamamoto JK
Leukemia; 1997 Apr; 11 Suppl 3():98-101. PubMed ID: 9209311
[TBL] [Abstract][Full Text] [Related]
14. Vaccination of cats with attenuated feline immunodeficiency virus proviral DNA vaccine expressing gamma interferon.
Gupta S; Leutenegger CM; Dean GA; Steckbeck JD; Cole KS; Sparger EE
J Virol; 2007 Jan; 81(2):465-73. PubMed ID: 17079309
[TBL] [Abstract][Full Text] [Related]
15. Immunization of cats against feline immunodeficiency virus (FIV) infection by using minimalistic immunogenic defined gene expression vector vaccines expressing FIV gp140 alone or with feline interleukin-12 (IL-12), IL-16, or a CpG motif.
Leutenegger CM; Boretti FS; Mislin CN; Flynn JN; Schroff M; Habel A; Junghans C; Koenig-Merediz SA; Sigrist B; Aubert A; Pedersen NC; Wittig B; Lutz H
J Virol; 2000 Nov; 74(22):10447-57. PubMed ID: 11044089
[TBL] [Abstract][Full Text] [Related]
16. Targeted lymph node immunization can protect cats from a mucosal challenge with feline immunodeficiency virus.
Finerty S; Stokes CR; Gruffydd-Jones TJ; Hillman TJ; Barr FJ; Harbour DA
Vaccine; 2001 Oct; 20(1-2):49-58. PubMed ID: 11567745
[TBL] [Abstract][Full Text] [Related]
17. Vaccination of cats against feline immunodeficiency virus (FIV): a matter of challenge.
Hesselink W; Sondermeijer P; Pouwels H; Verblakt E; Dhore C
Vet Microbiol; 1999 Sep; 69(1-2):109-10. PubMed ID: 10515278
[TBL] [Abstract][Full Text] [Related]
18. Protection against feline leukemia virus infection by use of an inactivated virus vaccine.
Hoover EA; Perigo NA; Quackenbush SL; Mathiason-DuBard CK; Overbaugh JM; Kloetzer WS; Elder JH; Mullins JI
J Am Vet Med Assoc; 1991 Nov; 199(10):1392-401. PubMed ID: 1666090
[TBL] [Abstract][Full Text] [Related]
19. Vaccination with inactivated virus but not viral DNA reduces virus load following challenge with a heterologous and virulent isolate of feline immunodeficiency virus.
Hosie MJ; Dunsford T; Klein D; Willett BJ; Cannon C; Osborne R; Macdonald J; Spibey N; Mackay N; Jarrett O; Neil JC
J Virol; 2000 Oct; 74(20):9403-11. PubMed ID: 11000209
[TBL] [Abstract][Full Text] [Related]
20. Vaccination against feline immunodeficiency virus using fixed infected cells.
Verschoor EJ; van Vliet AL; Egberink HF; Hesselink W; van Alphen WE; Joosten I; Boog CJ; Horzinek MC; de Ronde A
Vet Immunol Immunopathol; 1995 May; 46(1-2):139-49. PubMed ID: 7618254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
